Cell-specific roles of GRK2 in onset and severity of hypoxic-ischemic brain damage in neonatal mice
Introduction
Perinatal hypoxia-ischemia (HI) often leads to serious and permanent brain injury in the human neonate. The underlying mechanisms leading to cell death in the brain after HI are numerous and complex and only partially understood (Ferriero, 2004).
We have shown previously that the level of G protein-coupled receptor kinase 2 (GRK2) in whole brain homogenates is decreased after neonatal HI (Lombardi et al., 2004, Nijboer et al., 2008). Cerebral GRK2 expression is also reduced in animal models of Alzheimer and Parkinson disease (Burgos-Ramos et al., 2008, Suo et al., 2004, Ahmed et al., 2008). Moreover, GRK2+/− mice that express 50% of the protein develop both earlier and more pronounced brain injury after exposure to neonatal HI (Nijboer et al., 2008). Homozygous GRK2−/− mice die in utero (Jaber et al., 1996).
GRKs are key kinases involved in regulation of signaling via G protein-coupled receptors (GPCR) such as chemokine receptors and metabotropic glutamate receptors, via a process called homologous desensitization. More recently, it has been revealed that GRK2 also regulates cellular signaling by direct interaction with several downstream molecules including p38 MAP kinase (Reiter and Lefkowitz, 2006, Ribas et al., 2007). In vitro studies have demonstrated that GRK2 binds and phosphorylates p38 MAP kinase, thereby preventing activation of p38 (Peregrin et al., 2006). GRK2 can thus function as an endogenous p38 inhibitor in vitro. However, the in vivo relevance of changes in GRK2 for p38-dependent processes is unknown. Numerous factors that contribute to brain injury, like reactive oxygen species and cytokines, upregulate the activity of p38 (Cuenda and Rousseau, 2007). In addition, p38 is a major kinase involved in microglial activation and cytokine production in the brain (Koistinaho and Koistinaho, 2002). Activation of cerebral microglia and production of pro-inflammatory cytokines is thought to aggravate brain injury (Silverstein et al., 1997, Hedtjarn et al., 2004). In the literature, the general idea is that microglial activation is induced as a consequence of neuronal injury (Saliba and Henrot, 2001). More recent evidence suggests that in the neonatal HI brain microglia also contribute to an early phase of inflammation by increasing early cytokine expression (Dommergues et al., 2003, Fox et al., 2005, Bye et al., 2007, Nijboer et al., 2009).
The aim of this study was to delineate the role of GRK2 in microglia/macrophages or in forebrain neurons in determining the onset and magnitude of neonatal HI brain damage, p38 activation and cytokine production.
Section snippets
Animals
Experiments were performed in accordance with national guidelines (WOD, 1996) and were approved by the University Medical Center Utrecht experimental animal care committee.
We used heterozygous GRK2+/− and wildtype (WT) C57BL/6J littermates (Jaber et al., 1996). Animals with cell-specific reduction of GRK2 were obtained using Cre-Lox technology; LysM-Cre+/+ males (B6.129P2-Lyzstm1(cre)Ifo/J) or CamKIIα-Cre+/+ males ((Camk2a-cre)T29-1Stl/J; both Jackson Laboratory) were crossed with GRK2f/+
Role of microglial/macrophage GRK2 in HI brain damage
To determine the contribution of GRK2 in microglia/macrophages to onset and severity of brain damage, we used mice in which GRK2 was only reduced in lysozyme M (LysM)-positive cells (microglia/macrophages/granulocytes). GRK2 protein was ∼50% reduced in isolated LysM-GRK2f/+ microglia compared to control LysM-GRK2+/+ microglia, but not in LysM-GRK2f/+ astrocytes (Fig. 1A). LysM is also expressed in granulocytes and therefore, GRK2 will also be reduced in these cells. We have previously shown
Discussion
Previously, we showed that neonatal HI brain damage is accelerated and aggravated in mice with reduced GRK2 levels in all cells (GRK2+/- mice) (Nijboer et al., 2008). These findings indicated that the endogenous level of GRK2 is a critical player in HI brain damage. In the present study, we employed Cre-Lox technology to decrease GRK2 in specific cell types. This approach allowed us to identify cell-specific effects of low GRK2 on onset and severity of neonatal HI brain damage.
In LysM-GRK2f/+
Acknowledgments
This study was supported by the Wilhelmina Children’s Hospital Fund and the European Commission (Sixth Framework Program, contract no. LSHM-CT-2006-036534, NEOBRAIN). The authors thank I. den Hartog and J. Zijlstra for excellent technical assistance.
References (39)
- et al.
Minocycline provides protection against beta-amyloid(25–35)-induced alterations of the somatostatin signaling pathway in the rat temporal cortex
Neuroscience
(2008) - et al.
Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration
Exp. Neurol.
(2007) - et al.
P38 MAP-kinases pathway regulation, function and role in human diseases
Biochim. Biophys. Acta
(2007) - et al.
Phosphorylation-independent regulation of metabotropic glutamate receptor signaling by G protein-coupled receptor kinase 2
J. Biol. Chem.
(2002) - et al.
Early microglial activation following neonatal excitotoxic brain damage in mice. a potential target for neuroprotection
Neuroscience
(2003) - et al.
Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38
Cell Signal.
(2001) - et al.
Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells
J. Biol. Chem.
(1997) - et al.
Essential role for TrkB receptors in hippocampus-mediated learning
Neuron
(1999) - et al.
Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK
Curr. Biol.
(2006) - et al.
GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling
Trends Endocrinol. Metab.
(2006)
The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling
Biochim. Biophys. Acta
Cytokines and perinatal brain injury
Neurochem. Int.
G protein-coupled receptor kinases regulate metabotropic glutamate receptor 5 function and expression
Neuropharmacology
Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model
Exp. Neurol.
Changes in the G-protein-coupled receptor desensitization machinery during relapsing-progressive experimental allergic encephalomyelitis
J. Neuroimmunol.
Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment
J. Neurochem.
Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
J. Neurosci. Res.
Neonatal brain injury
N. Engl. J. Med.
Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion
J. Cereb. Blood Flow Metab.
Cited by (29)
Double life: How GRK2 and β-arrestin signaling participate in diseases
2022, Cellular SignallingRole of microglia in a mouse model of paediatric traumatic brain injury
2017, Brain, Behavior, and ImmunityCitation Excerpt :In this adult TBI model, behavioural improvements and reduced lesion volume at 1-day post-TBI were lost by 4 days post-TBI (Bye et al., 2007). An early but transient therapeutic effect of minocycline has also been reported following hypoxic-ischemic injury in the mouse (Fox et al., 2005; Nijboer et al., 2010), indicating that this effect of minocycline is not specific to TBI. A limitation of these previous studies and our current study is that we did not test whether behavioural outcomes were improved, despite no change in neuropathology.
G Protein-Coupled Receptor Kinases in the Inflammatory Response and Signaling
2017, Advances in ImmunologyCitation Excerpt :Furthermore, altering the levels of GRK2 influences the activation of p38 and its functionality including differentiation and cytokine production. This alteration holds true in murine GRK2+/− macrophages and microglial cells; both of these cells exhibit increased p38 activation and TNFα production in response to LPS (Nijboer et al., 2010). In contrast to this, complete GRK2 silencing in mast cells decreases cytokine production (IL-6 and IL-13) in a p38-dependent manner during antigen-induced degranulation (Subramanian, Gupta, Parameswaran, & Ali, 2014).
Monocytes/macrophages control resolution of transient inflammatory pain
2014, Journal of PainCitation Excerpt :These findings further support the hypothesis that the cytokine profile of peripheral monocytes/macrophages determines whether these cells are capable of inhibiting the pain response. In our previous studies, we showed that GRK2 levels of primary microglia cultures from LysM-GRK2+/− mice were reduced by approximately 50% compared to WT microglia.29,42 However, in the present study, we show that the level of GRK2 protein or mRNA in freshly isolated naive microglia or in microglia isolated from the spinal cord of LysM-GRK2+/− mice at 24 hours after intraplantar IL-1β was not different from the level of GRK2 protein or mRNA in WT microglia.
Sciatic nerve injury: A simple and subtle model for investigating many aspects of nervous system damage and recovery
2014, Journal of Neuroscience MethodsCitation Excerpt :An additional method for gene transfer into the sciatic nerve by muscle injection of an inactivated virus has been described (Kato et al., 2003). The powerful Cre/loxP system for targeted gene manipulation, widely used in the mouse (Eijkelkamp et al., 2010b; Nijboer et al., 2010), has recently been adapted for the rat nervous system (Schonig et al., 2012) along with other transgenic technologies (Huang et al., 2011; Tong et al., 2011). Immune cell infiltration into the nerve after axotomy has been measured by transplantation of GFP-labeled precursors (Pan et al., 2009), a field of particular interest given the use of precursor cell transplants to promote and support nerve regeneration.
Astrocyte GRK2 as a novel regulator of glutamate transport and brain damage
2013, Neurobiology of DiseaseCitation Excerpt :In the present study, we used GFAP-GRK2+/− mice to study the role of GRK2 in astrocytes. In contrast to the exacerbated HI brain damage that develops in mice with cell-specific reduction of GRK2 in forebrain neurons (CamKIIα-GRK2+/− mice) (Nijboer et al., 2010), we show here that reduction of GRK2 in astrocytes reduces cerebral infarct size after HI. These data point out that GRK2 has a cell-specific effect on HI-induced brain damage.